Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study

Manabu Ogita, Katsumi Miyauchi, Takeshi Morimoto, Hiroyuki Daida, Takeshi Kimura, Takafumi Hiro, Yoshihisa Nakagawa, Masakazu Yamagishi, Yukio Ozaki, Masunori Matsuzaki

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.

Original languageEnglish
Pages (from-to)275-280
Number of pages6
JournalAtherosclerosis
Volume226
Issue number1
DOIs
Publication statusPublished - 01-01-2013

Fingerprint

Acute Coronary Syndrome
Matrix Metalloproteinases
Matrix Metalloproteinase 3
Matrix Metalloproteinase 2
Matrix Metalloproteinase 1
Linear Models
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atherosclerosis

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Ogita, Manabu ; Miyauchi, Katsumi ; Morimoto, Takeshi ; Daida, Hiroyuki ; Kimura, Takeshi ; Hiro, Takafumi ; Nakagawa, Yoshihisa ; Yamagishi, Masakazu ; Ozaki, Yukio ; Matsuzaki, Masunori. / Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study. In: Atherosclerosis. 2013 ; Vol. 226, No. 1. pp. 275-280.
@article{f825111ae91146da8fddcf01bab1ef1a,
title = "Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study",
abstract = "Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.",
author = "Manabu Ogita and Katsumi Miyauchi and Takeshi Morimoto and Hiroyuki Daida and Takeshi Kimura and Takafumi Hiro and Yoshihisa Nakagawa and Masakazu Yamagishi and Yukio Ozaki and Masunori Matsuzaki",
year = "2013",
month = "1",
day = "1",
doi = "10.1016/j.atherosclerosis.2012.10.063",
language = "English",
volume = "226",
pages = "275--280",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study. / Ogita, Manabu; Miyauchi, Katsumi; Morimoto, Takeshi; Daida, Hiroyuki; Kimura, Takeshi; Hiro, Takafumi; Nakagawa, Yoshihisa; Yamagishi, Masakazu; Ozaki, Yukio; Matsuzaki, Masunori.

In: Atherosclerosis, Vol. 226, No. 1, 01.01.2013, p. 275-280.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome - Subanalysis of the JAPAN-ACS study

AU - Ogita, Manabu

AU - Miyauchi, Katsumi

AU - Morimoto, Takeshi

AU - Daida, Hiroyuki

AU - Kimura, Takeshi

AU - Hiro, Takafumi

AU - Nakagawa, Yoshihisa

AU - Yamagishi, Masakazu

AU - Ozaki, Yukio

AU - Matsuzaki, Masunori

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.

AB - Background: Matrix metalloproteinases (MMPs) have been implicated in development of atherosclerosis. MMPs are activated in patients with acute coronary syndrome (ACS). However, little data exist regarding the correlation between circulating levels of MMPs and plaque volume (PV) in patients with ACS. We therefore evaluated the impact of MMPs on coronary PV as a post hoc analysis from the JAPAN-ACS study. Methods: The multicenter JAPAN-ACS trial revealed that aggressive statin therapy for patients with ACS significantly reduces coronary PV determined by intravascular ultrasound (IVUS). We studied 248 ACS patients who had serial IVUS examinations over 8-12 months in the trial. For each patient, MMP-1, 2, and 3 were measured both at baseline and at study end to evaluate the correlation between the percent change of PV and MMP levels. Results: MMP-3 levels were significantly decreased during the follow-up period (100 ng/mL to 73 ng/mL, p < 0.001), in contrast, MMP-1, -2 levels were significantly increased. MMP-3 levels at follow-up correlated with coronary plaque regression (p for trend = 0.016). A multivariable linear regression model showed both MMP-2 and MMP-3 levels at follow-up were independent variables for change of coronary PV (p = 0.038 and p = 0.016, respectively). Conclusion: Circulating MMPs levels are associated with changes in coronary plaque volume determined by serial IVUS in patients with ACS.

UR - http://www.scopus.com/inward/record.url?scp=84871372560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871372560&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2012.10.063

DO - 10.1016/j.atherosclerosis.2012.10.063

M3 - Article

C2 - 23159100

AN - SCOPUS:84871372560

VL - 226

SP - 275

EP - 280

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -